Mitsubishi Tanabe Pharma
E554263
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Mitsubishi Tanabe Pharma canonical | 2 |
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| alternativeName |
MTPC
NERFINISHED
ⓘ
Mitsubishi Tanabe Pharma Corporation NERFINISHED ⓘ |
| country | Japan ⓘ |
| engagesIn |
biologic drug development
ⓘ
clinical research ⓘ drug discovery ⓘ |
| focusesOn | research and development of innovative medicines ⓘ |
| foundedBy | Mitsubishi Chemical Holdings Group NERFINISHED ⓘ |
| hasResearchCenter |
Osaka research facilities
ⓘ
Yokohama research facilities ⓘ |
| hasSubsidiary |
Mitsubishi Tanabe Pharma America
NERFINISHED
ⓘ
Mitsubishi Tanabe Pharma Development America NERFINISHED ⓘ Mitsubishi Tanabe Pharma Europe NERFINISHED ⓘ |
| headquartersLocation |
Osaka
NERFINISHED
ⓘ
Tokyo ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| languageOfWorkOrName | Japanese ⓘ |
| legalForm | Kabushiki gaisha ⓘ |
| memberOf | Mitsubishi Group NERFINISHED ⓘ |
| notableProduct |
Radicava
NERFINISHED
ⓘ
Radicut NERFINISHED ⓘ edaravone NERFINISHED ⓘ |
| parentOrganization | Mitsubishi Chemical Group NERFINISHED ⓘ |
| predecessor |
Mitsubishi Pharma
NERFINISHED
ⓘ
Tanabe Seiyaku NERFINISHED ⓘ |
| product |
autoimmune disease treatments
ⓘ
biopharmaceuticals ⓘ cardiovascular drugs ⓘ diabetes drugs ⓘ neurology drugs ⓘ prescription drugs ⓘ vaccines ⓘ |
| regionServed |
Asia
ⓘ
Europe ⓘ Japan ⓘ North America ⓘ |
| stockExchange | Tokyo Stock Exchange NERFINISHED ⓘ |
| therapeuticArea |
autoimmune diseases
ⓘ
cardiovascular diseases ⓘ diabetes ⓘ neurology ⓘ |
| tickerSymbol | 4508 ⓘ |
| website | https://www.mt-pharma.co.jp ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.